Filter news stories by category:
-
UCLH news
21 January 2022
UCLH has teamed up with Air Ambulance Kent Surrey Sussex (KSS) to create an additional module to its Airway Matters, Massive Open Online Course (MOOC).
-
Research news
20 January 2022
A third ‘booster’ dose of COVID-19 vaccine successfully raises antibody levels that neutralise the Omicron variant, according to laboratory findings from the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre and the Francis Crick Institute.
-
Research news
17 January 2022
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death, according to the results of a trial at UCLH and UCL.
-
UCLH news
10 January 2022
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
-
Research news
07 January 2022
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
-
UCLH news
06 January 2022
David Probert has been granted honorary professor status at UCL’s new Global Business School for Health (GBSH).
-
UCLH news
04 January 2022
A minimally invasive technique for treating prostate cancer has been used for the first time in the NHS at UCLH. It can be used with precision to treat the affected area, reducing side effects.
-
UCLH news
02 January 2022
A new national proton beam therapy centre based at UCLH has treated its first patients.
-
UCLH news
31 December 2021
Congratulations to all our UCLH people who have been recognised in the Queen’s New Year Honours 2022 list.
-
UCLH news
21 December 2021
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
